Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
49.10
+1.43 (3.00%)
Nov 22, 2024, 4:00 PM EST - Market closed
Cytokinetics Analyst Ratings
Total Analysts
16
Consensus Rating
Buy
Price Target
$83.67
Upside
+70.41%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +46.64% | Nov 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +144.40% | Nov 19, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +144.40% | Nov 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +144.40% | Nov 11, 2024 |
RBC Capital | RBC Capital | Buy Initiates $80 | Buy | Initiates | $80 | +62.93% | Nov 8, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +144.40% | Nov 7, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Oct 18, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $120 | Strong Buy | Reiterates | $120 | +144.40% | Oct 17, 2024 |
Needham | Needham | Strong Buy Reiterates $72 | Strong Buy | Reiterates | $72 | +46.64% | Oct 17, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $120 | Strong Buy | Maintains | $90 → $120 | +144.40% | Oct 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +83.30% | Sep 30, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +83.30% | Sep 20, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $90 | Strong Buy | Reiterates | $90 | +83.30% | Sep 9, 2024 |
JP Morgan | JP Morgan | Buy Maintains $65 → $71 | Buy | Maintains | $65 → $71 | +44.60% | Sep 5, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $78 | Buy | Reiterates | $78 | +58.86% | Sep 4, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.